News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News Black Patients With Chest Pain Differ From Whites, but Risks Are Similar Michael O'Riordan December 23, 2021
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Daily News Discharge Safe as Early as a Day After Primary PCI for STEMI L.A. McKeown December 15, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Conference News AHA 2021 Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders L.A. McKeown November 14, 2021
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Daily News Zero CAC Questionable for Ruling Out Obstructive CAD in Young Adults Michael O'Riordan November 02, 2021
News Daily News Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends Shelley Wood November 01, 2021
News Daily News New Chest Pain Guidelines Out at Last: Most Tests Have a Role Michael O'Riordan October 28, 2021
News Conference News TCT 2021 NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy L.A. McKeown October 22, 2021
News Daily News Could a Coronary Calcium Test Rule Out CAD in Chest Pain? Michael O'Riordan October 21, 2021
News Conference News EACTS 2021 More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients Michael O'Riordan October 18, 2021